|
N-nitroso-vancomycin
|
|
|
|
N-nitroso-varenicline
|
|
|
|
N-nitroso-desmethyl-venlafaxine
|
|
|
|
N-nitroso-vibegron
|
|
|
|
N-nitroso-vilanterol
|
|
|
|
N-nitroso-viloxazine
|
|
|
|
N-nitroso-vortioxetine
|
|
|
|
N-nitroso-desmethyl-zolmitriptan
|
|
|
|
|
伊沙佐米雜質(zhì)7
|
|
|
|
伊沙佐米雜質(zhì)9
|
|
|
|
伊沙佐米雜質(zhì)11
|
50-75-9
|
|
|
伊沙佐米雜質(zhì)12
|
50-73-7
|
|
|
伊沙佐米雜質(zhì)13
|
50-82-8
|
|
|
伊沙佐米雜質(zhì)24
|
2872629-73-5
|
|
|
伊沙佐米雜質(zhì)15
|
|
|
|
伊沙佐米雜質(zhì)16
|
2806031-79-6
|
|
|
伊沙佐米雜質(zhì)17
|
|
|
|
伊沙佐米雜質(zhì)18
|
1429055-05-9
|
|
|
伊沙佐米雜質(zhì)19
|
|
|
|
伊沙佐米雜質(zhì)20
|
|
|
|
伊沙佐米雜質(zhì)21
|
|
|
|
伊沙佐米雜質(zhì)22
|
|
|
|
伊沙佐米雜質(zhì)23
|
|
|
|
伊沙佐米雜質(zhì)25
|
|
|
|
伊沙佐米雜質(zhì)26
|
|
|
|
奈諾沙星對映異構(gòu)體
|
|
|
|
奈諾沙星差向異構(gòu)體1
|
|
|
|
奈諾沙星差向異構(gòu)體2
|
378746-65-7
|
|
|
奈諾沙星雜質(zhì)A
|
|
|
|
奈諾沙星雜質(zhì)B
|
|
|
|
奈諾沙星雜質(zhì)C
|
|
|
|
奈諾沙星雜質(zhì)D
|
|
|
|
奈諾沙星雜質(zhì)E
|
|
|
|
奈諾沙星雜質(zhì)F
|
|
|
|
奈諾沙星雜質(zhì)G
|
|
|
|
奈諾沙星雜質(zhì)H
|
|
|
|
奈諾沙星雜質(zhì)I
|
|
|
|
奈諾沙星雜質(zhì)J
|
|
|
|
N-[(3S,5R)-5-甲基-3-哌啶基]氨基 甲酸叔丁酯
|
1203651-07-3
|
|
|
N-[(3R,5S)-5-甲基-3-哌啶基]氨基 甲酸叔丁酯
|
1270019-92-5
|
|
(3R,5R)-3-(Boc-amino)-5- Methylpiperidine
|
|
1227919-32-5
|
|
|
奈諾沙星中間體1雜質(zhì)1
|
|
|
|
奈諾沙星中間體1雜質(zhì)2
|
|
|
|
奈諾沙星原料雜質(zhì)1
|
|
|
|
奈諾沙星原料雜質(zhì)2
|
|
|
|
奈諾沙星中間體2雜質(zhì)1
|
|
|
|
奈諾沙星中間體2雜質(zhì)2
|
|
|
|
奈諾沙星中間體2雜質(zhì)3
|
|
|
|
蘋果酸奈諾沙星
|
951163-60-3
|
|
|
莫匹羅星EP雜質(zhì)B
|
1980-98-8
|
|
|
莫匹羅星EP雜質(zhì)C
|
85248-93-7
|
|
|
莫匹羅星EP雜質(zhì)C鈉鹽
|
85178-60-5
|
|
|
莫匹羅星EP雜質(zhì)D
|
71087-97-3
|
|
|
莫匹羅星EP雜質(zhì)E
|
71087-96-2
|
|
|
莫匹羅星EP雜質(zhì)F
|
167842-64-0
|
|
|
莫匹羅星EP雜質(zhì)I
|
|
|
|
莫匹羅星單胞菌酸A
|
66262-68-8
|
|
|
莫匹羅星4
|
|
|
|
莫匹羅星5
|
|
|
|
夫西地酸鈉EP雜質(zhì)A
|
80445-74-5
|
|
|
夫西地酸鈉EP雜質(zhì)B
|
|
|
|
依達(dá)拉奉雜質(zhì)6
|
124009-63-8
|
|
|
依達(dá)拉奉雜質(zhì) 32
|
852539-02-7
|
|
|
依達(dá)拉奉雜質(zhì) 35
|
|
|
|
依達(dá)拉奉雜質(zhì) 36
|
|
|
(3S,4R,4aS,7aR)-3-(cyclopropylmethyl)-4a-hydroxy-9-methoxy-3-methyl-7-oxo-2,3,4,4a,5, 6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium bromide
|
溴甲納曲酮雜質(zhì)1
|
1005410-37-6
|
|
|
溴甲納曲酮雜質(zhì)3
|
1005410-47-8
|
|
Potassium Clavulanate EP lmpurity M
|
克拉維酸鉀 EP 雜質(zhì)M
|
|
|
(1R,2S)-1-(3-(allyloxy)phenyl)-1-hydroxypropan-2-aminium chloride
|
(1R,2S)-1-(3-(烯丙氧基)苯)-1-羥基丙烷-2-氯化銨
|
|
|
|
氨氯地平雜質(zhì)82
|
|
|
|
((1SR,4RS)-7,7-二甲基-2-氧代雙環(huán)[2.2.1]庚-1-基)甲磺酸
|
|
|
|
((1SR,4SR.E)-3-(4-(羥甲基)亞芐基)-7,7-二甲基-2-氧代雙環(huán)[2.2.1]
庚-1-基)甲磺酸鈉
|
|
|
|
4-（(E)-((1SR,4SR)-7,7-二甲基-3-氧代-4-(磺甲基)二環(huán)[2.2.1]庚-2-亞基)甲基）苯甲酸
|
|
|
|
4-（(E)-((1SR,4SR)-7,7-二甲基-3-氧代-4-(磺甲基)二環(huán)[2.2.1]庚-2-亞基)甲基）苯甲醛鈉鹽
|
|
|
|
丙卡特羅雜質(zhì)1
|
59827-93-9
|
|
|
8-羥基喹啉 N-氧化物
|
1127-45-3
|
|
|
丙卡特羅原料硝化雜質(zhì)
|
|
|
2-(amino(carboxy)methyl)-5-(((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl)-3-nitroso-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
|
2-(氨基(羧基)甲基)-5-(((6-羥基-2-甲基-5-氧代-2,5-二氫-1,2,4-三嗪-3-基)硫代)甲基)-3-亞硝基-3,6-二氫-2H-1,3-噻嗪-4-羧酸
|
|
|
5-(acetoxymethyl)-2-(amino(carboxy)methyl)-3-nitroso-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
|
5-（乙酰氧基甲基）-2-（氨基（羧基）甲基）-3-亞硝基-3,6-二氫-2H-1,3-噻嗪-4-羧酸
|
|
|
sodium (R)-2-((R)-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)(carboxylato)methyl)-5-(((2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl)-3-nitroso-3,6-dihydro-2H-1,3-thiazine-4-carboxylate
|
鈉（R）-2-（（R）-（（E）-2-（2-氨基噻唑-4-基）-2-（甲氧基亞氨基）乙酰氨基）（羧基化）甲基）-5-（（（2-甲基-6-氧化-5-氧代-2,5-二氫-1,2,4-三嗪-3-基）硫代）甲基）-3-亞硝基-3,6-二氫-2H-1,3-噻嗪-4-羧酸酯
|
|
|
N-methylnitrous hydrazide
|
N-甲基-N-亞硝基-2-丙胺
|
|
|
Imrecoxib
|
|
395683-14-4
|
|
Imrecoxib Impurity 1
|
|
|
|
Imrecoxib Impurity 6
|
|
1338083-52-5
|
|
Imrecoxib Impurity 9
|
|
959003-56-6
|
|
Imrecoxib Impurity 92
|
|
|
|
Imrecoxib Impurity 4
|
|
197240-27-0
|
|
Imrecoxib Impurity 5
|
|
|
|
Imrecoxib Impurity 7
|
|
|
|
|
奧瑪環(huán)素
|
|
|
|
4-Beta異構(gòu)體
|
601455-29-2
|
|
|
奧瑪環(huán)素雜質(zhì)2
|
488819-64-3
|
|
|
奧瑪環(huán)素雜質(zhì)4
|
2272886-37-8
|
|
|
奧瑪環(huán)素雜質(zhì)M-2雜質(zhì)
|
885112-31-2
|
|
|
伊沙佐米雜質(zhì)8
|
1378314-08-9
|
|
|
伊沙佐米雜質(zhì)10
|
667403-46-5
|
|
|
伊沙佐米雜質(zhì)3
|
|
|
|
伊沙佐米雜質(zhì)4
|
|
|
|
伊沙佐米雜質(zhì)5
|
|
|
|
伊沙佐米雜質(zhì)6
|
|